MRI scans taken before prostate cancer treatment may already contain clues about which patients are most at risk for the disease returning after radiation. In a new study, Onofrio A Catalano and colleagues analyzed pretreatment prostate MRIs and found that certain features — especially when the tumor appeared to press on or invade nearby nerves — were linked to a later rise in PSA levels, a common sign of recurrence. If validated in larger studies, these imaging clues could help doctors tailor follow-up care and catch potential relapses sooner.
Read the Paper
Herold A, Pohl M, Korn SM, Weber M, Efstathiou JA, Saylor PJ, Huang SY, Harisinghani MG, Catalano OA. Prognostic value of MRI-derived features for biochemical recurrence after curative radiotherapy in prostate cancer. Abdom Radiol (NY). 2025 Sep 20. doi: 10.1007/s00261-025-05199-x. Epub ahead of print. PMID: 40974477. (PubMed page)